Welcome to the e-CCO Library!

OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Van Limbergen1,2, E. Wine3, A. Assa4, R. Sigall Boneh5, R. Shaoul6, M. Kori7, S. Cohen8, S. Peleg9, H. Shamaly10, A. On11, P. Milman12, L. Abramas5, T. Ziv Baran13, S. Grant14, A. Levine*5,13

Created: Friday, 22 February 2019, 9:41 AM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pibiri, P.(1)*;Sun, S.(1);Karmi, N.(1);Oelen, R.(2);de Jong, S.(1);Bangma, A.(1);Hermoso, M.(1);Paraskevopoulou, M.(3);Farahmand, S.(3);Weersma, R.(1);Bigaeva, E.(1);Festen, E.(1);Xia, G.(3);Teunis, J.(4);Bleck, B.(3);
Created: Friday, 14 July 2023, 10:43 AM
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study
Year: 2022
Source: ECCO'22
Authors: Shavit, Z.(1);Stein, R.(2);Aloi, M.(3);Ledder, O.(4);Focht, G.(4);Urlep, D.(5);Hyams, J.(6);Broide, E.(7);Vais, B.(8);Levine, J.(9);Shouval , D.(10);Matar, M.(10);Assa, A.(10);Rosh, J.(11);Hussey, S.(12);Markowitz, J.(13);Yerushalmy-Feler, A.(14);Miele, E.(15);Shaoul, R.(16);Russell, R.K.(17);Turner, D.(4);
Created: Friday, 11 February 2022, 3:52 PM
OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Haberman Ziv1, N. Loberman-Nachum1, S. Katya1, A. Di Segni1, G. Efroni1, T. Braun1, M. BenShoshan1, D. Shouval1, L.A. Denson2, A. Amir1, R. Unger3, B. Weiss1, CCF funded RISK Crohn Disease study

Created: Thursday, 30 January 2020, 10:12 AM
OP06: 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry
Year: 2021
Source: ECCO'21 Virtual
Authors: Ungaro, R.(1);Brenner, E.(2);Agrawal, M.(1);Gearry, R.B.(3);Kaplan, G.G.(4);Kissous-Hunt, M.(1);Ng, S.C.(5);Rahier, J.F.(6);Reinisch, W.(7);Steinwurz, F.(8);Zhang, X.(2);Lewis, J.D.(9);Kappelman, M.D.(2);Colombel, J.F.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Humbel1, P. Juillerat2, M. Scharl1, B. Misselwitz2, P. Schreiner1, A. Macpherson2, G. Rogler1, R. von Känel3, B. Yilmaz4, L. Biedermann*1

Created: Friday, 22 February 2019, 9:41 AM
OP06: Multiomic interrogation of the epithelium in active Ulcerative Colitis reveals dysregulated myeloid cells associated with non-response to anti-Tumour Necrosis Factor therapy.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jha , D.(1)*;Al-Taie , Z.(2);Krek , A.(3);Eshghi , S.(4);Tankelevich , M.(1);Meringer , H.(5);Cossarini , F.(6);Canales-Herrerias , P.(1);Livanos , A.E.(1); Polydorides , A.D.(7);Martin , J.(8);Ko , H.M.(9);McBride , J.(4);Hackney , J.(10);Colombel , J.F.(1);Argmann , C.(11);Suarez-Farinas , M.(11);Petralia , F.(11);Mehandru , S.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP06: The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis – A real-world cohort study
Year: 2022
Source: ECCO'22
Authors: Ovesen, P.D.(1);Ilvemark, J.F.K.F.(1);Attauabi, M.(1);Seidelin, J.B.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP07 The epidemiology of inflammatory bowel diseases among immigrants to Denmark: A population-based cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Agrawal1, S. Shrestha2, G. Corn3, N.M. Nielsen3, M. Frisch3, J.F. Colombel1, T. Jess3

Created: Thursday, 30 January 2020, 10:12 AM
OP07: Absolute and relative risks of kidney and urological complications in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yang, Y.(1)*;Ludviggson, J.F.(1,2);Olén, O.(3,4,5);Sjölander, A.(1);Carrero, J.J.(1,6);
Created: Friday, 14 July 2023, 10:43 AM
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Gul1, E. Jones1,2, Z. Matthews3, P. Sudhakar1,2,4, A. Treveil1,2, D. Divekar2,3, J. Buck3, M. Jefferson3, S. Armstrong5, A. Watson2,3, S. Carding2,3, U. Mayer6, P. Powell3, I. Hautefort1, T. Wileman2,3, T. Korcsmaros*1,2

Created: Friday, 22 February 2019, 9:41 AM
OP07: Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Lo, B.Z.S.(1);Liu, Z.(1,2);Bendtsen, F.(1);Igel, C.(2);Vind, I.(1);Burisch, J.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP07: Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
Year: 2022
Source: ECCO'22
Authors: Schreiber, S.(1);Feagan, B.(2,3);Peyrin-Biroulet, L.(4);Vermeire, S.(5);Faes, M.(6);Harris, K.(7);Oortwijn, A.(7);Daniele, P.(8);Patel, H.(6);Danese, S.(9,10);
Created: Friday, 11 February 2022, 3:52 PM
OP08 Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Axelrad1, O. Olen2, M. Sachs2, R. Erichsen3, L. Pedersen3, J. Halfvarson4, J. Askling2, A. Ekbom2, H.T. Sørensen3, J. Ludvigsson5

Created: Thursday, 30 January 2020, 10:12 AM
OP08: Automatic detection of enteric ulcers and erosions in capsule endoscopy using a convolutional neural network
Year: 2021
Source: ECCO'21 Virtual
Authors: SaraivaJr., M.(1);Afonso, J.(1);Ribeiro, T.(1);Cardoso, H.(1);Ferreira, J.(2);Andrade, P.(1);Jorge, R.(2);Lopes, S.(1);Macedo, G.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP08: Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. D’Haens*1, W. Reinisch2, S. D. Lee3, D. Tarabar4, E. Louis5, M. Kłopocka6, J. Klaus7, S. Schreiber8, D. I. Park9, X. Hébuterne10, K. J. Gorelick11, S. W. Martin12, A. Banerjee12, P. Nagy13, Y. Wang14, F. Cataldi14, W. J. Sandborn15

Created: Friday, 22 February 2019, 9:41 AM
OP08: Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jairath, V.(1,2)*;Feagan, B.G.(2);Silverberg, M.S.(3);Danese, S.(4);Gionchetti, P.(5);Löwenberg, M.(6);Bressler, B.(7);Ferrante, M.(8);Hart, A.(9);Lindner, D.(10);Escher, A.(10);Jones, S.(10);Shen, B.(11);Travis, S.(12);
Created: Friday, 14 July 2023, 10:43 AM
OP08: The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
Year: 2022
Source: ECCO'22
Authors: Danese, S.(1);Tran, J.(2);D'Haens, G.(3);Rubin, D.T.(4);Aoyama, N.(5);Zhou, W.(2);James, B.(2);Yao, X.(2);SanchezGonzalez, Y.(2);Panaccione, R.(6);
Created: Friday, 11 February 2022, 3:52 PM
OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.N. Quraishi1,2, Y.H. Oo3, A. Beggs4, D. Withers3, A. Acharjee4,5, N. Sharma1,2, S. Manzoor1, A.L. Hart6, D.R. Gaya7, N.J. Loman8, P.M. Hawkey1, K. Gerasimidis9, R. Hansen10, G. Gkoutous4,5,11, T.H. Iqbal1,2

Created: Thursday, 30 January 2020, 10:12 AM
OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Peyrin-Biroulet*1, J. Panés2, M. Chiorean3, J. Zhang4, S. Vermeire5, V. Jairath6, A. Yarur7, C. Cabell4, S. Naik4, W. J. Sandborn8

Created: Friday, 22 February 2019, 9:41 AM